Surgical Outcome of Hilar Plate Resection: Extended Hilar Bile Duct Resection Without Hepatectomy

Background We have done curative or palliative extended extrahepatic bile duct resection at the level of the hilar plate for selected patients with cholangiocarcinoma with hilar spreading, calling this procedure “hilar plate resection” (HPR), but the results of evaluating the clinical benefits of HP...

Full description

Saved in:
Bibliographic Details
Published in:Journal of gastrointestinal surgery 2014-06, Vol.18 (6), p.1131-1137
Main Authors: Noji, Takehiro, Tsuchikawa, Takahiro, Okamura, Keisuke, Shichinohe, Toshiaki, Tanaka, Eiichi, Hirano, Satoshi
Format: Article
Language:English
Subjects:
Adult
Aged
Aged, 80 and over
Bile Duct Neoplasms - surgery
Bile ducts
Bile Ducts, Extrahepatic - surgery
Bile Ducts, Intrahepatic
Cholangiocarcinoma
Cholangiocarcinoma - surgery
Female
Gastroenterology
Hepatectomy
Hepatectomy - adverse effects
Humans
Length of Stay
Male
Medicine
Medicine & Public Health
Middle Aged
Original Article
Palliative Care - methods
Retrospective Studies
Surgery
Surgical outcomes
Survival Rate
Thoracic surgery
Treatment Outcome
Veins & arteries
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background We have done curative or palliative extended extrahepatic bile duct resection at the level of the hilar plate for selected patients with cholangiocarcinoma with hilar spreading, calling this procedure “hilar plate resection” (HPR), but the results of evaluating the clinical benefits of HPR for cholangiocarcinoma with hilar spreading have not been reported. Patients and Methods Fifty-two patients with cholangiocarcinoma underwent HPR: the curative procedure was performed in 28 patients (cHPR group) and the palliative in 24 patients (pHPR group). In the same period, 128 patients with cholangiocarcinoma underwent major hepatectomy with intrahepatic cholangiojejunostomy (Hx group). These groups were compared in terms of post-operative complications and survival. Results There were no significant differences in the rate of patients with post-operative complications and in post-operative hospital stay. The overall cumulative 5-year survival rates for each procedure (Hx group, cHPR group and pHPR group) were 40, 38 and 11 %, respectively. There was no significant difference between the Hx and cHPR groups in survival rates ( p  = 0.87). Conclusion In conclusion, HPR appears to be safe and feasible for selected patients with cholangiocarcinoma. However, the indications for HPR should be restricted.
ISSN:1091-255X
1873-4626
DOI:10.1007/s11605-014-2490-8